Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $67
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE: SMG) with a Overweight and lowers the price target from $75 to $67.
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE: SMG) with a Overweight and lowers the price target from $75 to $67.